论文部分内容阅读
目的探讨静脉注射阿托品治疗先天性肥厚性幽门狭窄症的方法及疗效。方法应用静脉注射阿托品疗法治疗先天性肥厚性幽门狭窄症25例。静脉注射阿托品开始剂量为0．04 mg/(kg·d),每日增加0．01 mg/kg至显效。呕吐停止后阿托品改为口服,两周后停药。结果 24 例于用药后10 d内呕吐停止,显效时阿托品剂量在0．04-0．14 mg/(kg·d)之间。停药后无呕吐复发者。住院时间10-18 d。1例无效经手术治愈。结论静脉注射阿托品疗法治疗先天性肥厚性幽门狭窄症疗效满意,具有无创、并发症少等优点。
Objective To investigate the method and efficacy of intravenous atropine in the treatment of congenital hypertrophic pyloric stenosis. Methods 25 cases of congenital hypertrophic pyloric stenosis were treated with intravenous atropine therapy. The initial dose of intravenous atropine 0.04 mg / (kg · d), daily 0.01 mg / kg to markedly effective. After stopping vomiting atropine changed to oral, two weeks after withdrawal. Results Twenty-four patients stopped vomiting within 10 days after treatment. The effective dose of atropine was 0.04-0.14 mg / (kg · d). No withdrawal after vomiting relapse. Hospitalization time 10-18 d. 1 case was cured by surgery. Conclusion Intravenous atropine treatment of congenital hypertrophic pyloric stenosis satisfactory results, with non-invasive, less complications and so on.